The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,730.00
Bid: 2,726.00
Ask: 2,728.00
Change: 18.00 (0.66%)
Spread: 2.00 (0.073%)
Open: 2,706.00
High: 2,734.00
Low: 2,706.00
Prev. Close: 2,712.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

15 Feb 2024 14:59

RNS Number : 3263D
Coca-Cola HBC AG
15 February 2024
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Publication of Supplement to the Base Prospectus dated 19 December 2023

Zug, Switzerland 15 February 2024 - Coca-Cola HBC AG ("Coca-Cola HBC") announces today that the following supplement has been approved by the UK Financial Conduct Authority and is available for viewing:

Base Prospectus Supplement dated 15 February 2024 to the Base Prospectus dated 19 December 2023 in respect of the EUR 5,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V. as issuer and Coca-Cola HBC as guarantor (the "Supplement").

To view the Supplement and the Base Prospectus, please paste the following URL into the address bar of your browser:

 

https://www.coca-colahellenic.com/en/investor-relations/debt-investors

 

A copy of the Supplement has also been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Disclaimer

Please note that the information contained in the Supplement (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Supplement you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

 

 

 

 

Enquiries

 

Coca?Cola HBC Group

 

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

 john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Virginia Phillips

Investor Relations Manager

 

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager

Tel: +44 7597 562 978

claire.evans@cchellenic.com

 

 

 

ABOUT COCA-COLA HBC

 

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPZELFFZLLEBBQ
Date   Source Headline
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.